InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc. is a biotechnology company focused on the research, development, and commercialization of innovative pharmaceutical products. The company specializes in cannabinoid-based therapies, aiming to address unmet medical needs in areas such as dermatology, neurology, and rare diseases. InMed Pharmaceuticals Inc. leverages its proprietary platform to develop targeted drug delivery systems, with a pipeline that includes both clinical-stage and preclinical candidates. The company operates globally, collaborating with research institutions and healthcare partners to advance its therapeutic solutions. Listed on the Börse Berlin Stock Exchange, InMed Pharmaceuticals Inc. plays a significant role in the biotechnology sector, contributing to advancements in medical science and patient care.